Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Sep;8(8):2793-2795.
doi: 10.1016/j.jaip.2020.06.046. Epub 2020 Jul 8.

Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma

Estefanía Mira  1 , Oscar A Yarce  2 , Consuelo Ortega  3 , Silvia Fernández  3 , Natalia M Pascual  1 , Cristina Gómez  1 , Miguel A Alvarez  4 , Ignacio J Molina  5 , Rafael Lama  1 , Manuel Santamaria  6
Affiliations
Case Reports

Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma

Estefanía Mira et al. J Allergy Clin Immunol Pract. 2020 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Upper panel: CT displaying bilateral pulmonary involvement in the form of nodular consolidations and ground-glass opacities primarily in the left lower lobe (red arrow) and small-size left pleural effusion (black arrow). Lower panel: CT of the chest 6 days after COVID-19 convalescent donor plasma transfusion showing almost complete resolution of bilateral lung lesions pattern. CT, Computed tomography.
Figure 2
Figure 2
(A) Flow cytometric double fluorescence analysis of CD8 cells showing coexpression of surface CD3 (upper panel) and intracytoplasmic TNF-α (middle panel) or IFN-γ (lower panel) after cell stimulation. (B) Blood peripheral T lymphocytes and NK-cell counts determined on days 0, 3, and 7 postinfusion of COVID-19 convalescent plasma.
See this image and copyright information in PMC

References

    1. Burton D.R. Antibodies, viruses and vaccines. Nat Rev Immunol. 2002;2:706–713. - PubMed
    1. Fill L., Hadney L., Graven K., Persaud R., Hostoffer R. The clinical observation of a CVID patient infected with COVID-19. Ann Allergy Asthma Immunol. 2020;125:112–114. - PMC - PubMed
    1. Quinti I., Lougaris V., Milito C., Cinetto F., Pecoraro A., Mezzaroma I. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. J Allergy Clin Immunol. 2020;146:211–213.e4. - PMC - PubMed
    1. Soresina A., Moratto D., Chiarini M., Paolillo C., Baresi G., Foca E. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr Allergy Immunol. 2020;31:565–569. - PMC - PubMed
    1. Zheng M., Gao Y., Wang G., Song G., Liu S., Sun D. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533–535. - PMC - PubMed

Publication types

Supplementary concepts